News

Article

AJMC® in the Press, February 9, 2024

Author(s):

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

Articles in Medriva and Becker’s Payer Issues referenced a study published in the February 2024 issue of The American Journal of Managed Care® (AJMC®). The study, “Screening for Health Literacy, Social Determinants, and Discrimination in Health Plans,” found that calling patients at the time of enrollment in a health plan could help in collecting health literacy data.

A piece by PharmExec referenced an article published by AJMC’s sister site, The Center for Biosimilars®. The article, “Why Pharmacovigilance Is Important for Biosimilars,” emphasized the need for constant pharmacovigilance among clinicians due to how many factors can affect the quality and performance of biosimilars.

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Videos
Gordon Crofoot, MD, PA
David Awad, PharmD, BCOP
Merrill H. Stewart, MD
Saad Z. Usmani, MD, MBA, FACP, FASCO, Memorial Sloan Kettering Cancer Center
Andrew Evens, DO, MBA, MSc, deputy director for clinical services and chief physician officer, Rutgers Cancer Institute and Jack & Sheryl Morris Cancer Center
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo